Tempus AI, Inc.
TEM
Clasificación en acciones
#1866
Tempus AI, Inc. operates as a healthcare technology company in the United... Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Precio por acción
$64.74
Última sincronización: 2026-10-19
Capitalización bursátil
$11.35B
Cambio (1 día)
0.03%
Cambio (1 año)
-29.97%
País
US
Comercio Tempus AI, Inc. (TEM)
Categoría
Healthcare
Número de acciones en circulación de Tempus AI, Inc. (TEM)
Número de acciones en circulación al June 2026: 179.92M
Según los últimos informes financieros y el precio de las acciones de Tempus AI, Inc., el número actual de acciones en circulación es 179.92M. Al final de December 2023, la empresa tenía 154.17M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Tempus AI, Inc. (TEM) desde 2019 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 179.92M | 10.98% |
| 2024 | 162.12M | 5.15% |
| 2023 | 154.17M | -9.24% |
| 2022 | 169.88M | 0.00% |
| 2021 | 169.88M | 0.00% |
| 2020 | 169.88M | 5.71% |
| 2019 | 160.71M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 453.00M | 151.78% |
US
|
|
| 104.47M | -41.93% |
AU
|
|
| 205.38M | 14.15% |
US
|
|
| 129.98M | -27.75% |
US
|
|
| - | - |
US
|
